New Lozenge Improves Chances of Quitting SmokingOctober 31, 2001
Research Summary
A recently released study found that a new nicotine lozenge can triple a smoker's chance of quitting, Reuters reported Oct. 29.The study also showed that NiQuitin CQ is more effective than nicotine patches, gum, inhalers, or nasal sprays in helping smokers quit.
"It trebles the success rate and surpasses all forms of nicotine-replacement therapy to date," said Dr. Chris Steele, who runs one of Europe's biggest stop-smoking clinics.
Steele conducted a study involving 1,800 smokers in Britain and the United States. The results showed that smokers who received the lozenges were much more likely to stop smoking than those who took a placebo.
NiQuitin CQ, made by GlaxoSmithKline, was designed to reduce cravings and withdrawal symptoms.
The study's findings will be published in an upcoming issue of the journal Archives of Internal Medicine, Steele said.
COMMENTS ON THIS ARTICLE: